Metal-phenolic networks with ferroptosis to deliver NIR-responsive CO for synergistic therapy

• Published in: Journal of controlled release 2022-12, Vol.352, p.313-327
• Main Authors: Li, Jiamei, Zhou, Yang, Liu, Jiaqi, Yang, Xiaotong, Zhang, Kai, Lei, Lei, Hu, Haili, Zhang, Huilin, Ouyang, Liang, Gao, Huile
• Format: Article
• Language: English
• Subjects: Breast Neoplasms - pathology; Cell Line, Tumor; Checkpoint blockade; CO therapy; Combined Modality Therapy; Female; Ferroptosis; Humans; Hyperthermia, Induced; Metal-organic networks; Nanoparticles; Phototherapy; Photothermal therapy
• ISSN: 0168-3659; 1873-4995
• DOI: 10.1016/j.jconrel.2022.10.025

As an endogenous gasotransmitter, CO has achieved tremendous advances in cancer treatment through selectively killing cancer cells. However, the application of CO in tumor immunotherapy has not been reported and the tumor targeting delivery is still a tremendous challenge. Herein, thermosensitive boronic acid group-containing CO prodrug was synthesized and fabricated with tannic acid (TA) and iron (Fe) to form metal-phenolic networks, and then loaded with near-infrared (NIR) photothermal agent IR820 to form FeCO-IR820@FeIIITA for combinational therapy of CO and photothermal therapy. Ferroptosis can also be enhanced due to the Fe3+ incorporation. After TA reduced Fe3+ into Fe2+, Fe2+ might lead to intracellular Fenton reaction. Furthermore, in combination with CTLA-4 blockade immunotherapy, FeCO-IR820@FeIIITA remarkably inhibited breast tumor growth, suppressed the lung metastasis and improved the antitumor immune response. To summarize, FeCO-IR820@FeIIITA provides a potential novel option for CO/photothermal/immune synergistic therapy with enhanced ferroptosis through simple compositions and facile synthesis process. [Display omitted]